NRX Pharmaceuticals, Inc. (NRXP)
3.455
-0.22
(-5.86%)
USD |
NASDAQ |
Aug 26, 16:00
3.455
0.00 (0.00%)
After-Hours: 16:00
NRX Pharmaceuticals Shareholders Equity (Quarterly) : -0.17M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.17M |
| March 31, 2026 | -13.82M |
| December 31, 2025 | -15.94M |
| September 30, 2025 | -25.76M |
| June 30, 2025 | -35.62M |
| March 31, 2025 | -25.16M |
| December 31, 2024 | -23.22M |
| September 30, 2024 | -18.82M |
| June 30, 2024 | -18.39M |
| March 31, 2024 | -15.07M |
| December 31, 2023 | -11.73M |
| September 30, 2023 | -6.217M |
| June 30, 2023 | -2.808M |
| March 31, 2023 | -0.284M |
| December 31, 2022 | 7.409M |
| September 30, 2022 | 16.78M |
| June 30, 2022 | 25.35M |
| March 31, 2022 | 31.69M |
| Date | Value |
|---|---|
| December 31, 2021 | 20.81M |
| September 30, 2021 | 8.481M |
| June 30, 2021 | -39.77M |
| March 31, 2021 | 1.22M |
| December 31, 2020 | -43.77M |
| September 30, 2020 | 3.201M |
| June 30, 2020 | 3.626M |
| March 31, 2020 | 3.776M |
| December 31, 2019 | 29.50M |
| September 30, 2019 | 39.25M |
| June 30, 2019 | 47.99M |
| March 31, 2019 | 69.73M |
| December 31, 2018 | 69.54M |
| September 30, 2018 | 69.51M |
| June 30, 2018 | 69.48M |
| March 31, 2018 | 69.49M |
| December 31, 2017 | 69.47M |
| September 30, 2017 | 0.0238M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 33.88B |
| Pfizer Inc. | 85.19B |
| Oramed Pharmaceuticals, Inc. | 317.47M |
| Yarrow Bioscience, Inc. | 22.06M |
| ANI Pharmaceuticals, Inc. | 597.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.16M |
| Total Liabilities (Quarterly) | 34.33M |
| Debt to Equity Ratio | -7.329 |
| Current Ratio | 0.8608 |
| Net Debt Paydown Yield | 0.81% |